Dr. Allen L Cohn MD Medical Oncologist

Dr. Allen Cohn is a medical oncologist in Denver, Colorado. He is affiliated with multiple hospitals in the area, including Presbyterian-St. Luke's Medical Center and Rose Medical Center. He received his medical degree from University of Maryland School of Medicine and has been in practice for 25 years. Dr. Cohn accepts several types of health insurance, listed below. He is one of 2 doctors at Presbyterian-St. Luke's Medical Center and one of 3 at Rose Medical Center who specialize in Medical Oncology.

Are you Dr. Allen Cohn? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology, Gastrointestinal Cancer, Genitourinary

Hospital Affiliation

Presbyterian-St. Luke's Medical Center
High performing in Cancer

Rose Medical Center
High performing in Cancer

Sky Ridge Medical Center

Education & Medical Training

University of Colorado
Residency, Internal Medicine, 1988

University of Colorado
Internship, Internal Medicine, 1985 - 1986

University of Maryland School of Medicine
Class of 1985

U Colorado
Fellowship, Hematology and Oncology (IM), 1991

Certifications & Licensure

American Board of Internal Medicine
Certified 26 years in Internal Medicine

American Board of Internal Medicine
Certified 23 years in Medical Oncology

CO State Medical License
Active through 2013

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services
2012

Publications & Presentations

Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial.
Kim, E. S.,Neubauer, M.,Cohn, A.,Schwartzberg, L.,Garbo, L.,Caton, J.,Robert, F.,Reynolds, C.,Katz, T.,Chittoor, S.,Simms, L.,Saxman, S.

TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial.
Fuchs, C. S.,Fakih, M.,Schwartzberg, L.,Cohn, A. L.,Yee, L.,Dreisbach, L.,Kozloff, M. F.,Hei, Y. J.,Galimi, F.,Pan, Y.,Haddad, V.,Hsu, C. P.,Sabin, A.,Saltz, L.

Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomised Phase 2 study.
Richards, D.,Kocs, D. M.,Spira, A. I.,David McCollum, A.,Diab, S.,Hecker, L. I.,Cohn, A.,Zhan, F.,Asmar, L.

See all 23 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem PPO
  • BCBS Blue Card PPO
  • BCBS North Carolina BlueOptions PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Cofinity PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Rocky Mountain Group/Indiv - HMO/Private Pay
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.